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Dear Editor,
We thank Dr. Brummel and his team
[1] for their interest in our paper [2].
We agree that the prevalence of
delirium in awake ICU patients in our
study is similar to that found in earlier
studies (42.5 % in the study by Ely
et al. [3], 31 % in our study). How-
ever, we propose that reports on
delirium should be stratified for a
sedation score during the assessment,
because the apparent prevalence of
delirium is dependent on how a
depressed level of consciousness after
sedation stop is interpreted. For
instance, of 471 daily evaluations
completed during the study by Ely
et al. [3], a diagnosis by the reference
standard of delirium was made in
25.2 %, stupor in 21.3 %, and coma
in 28.5 % of all observations. Yet, the
authors report that delirium occurred
in 83.3 % of their patients. Unfortu-
nately, in the validation studies
neither CAM-ICU nor ICDSC
described how sedated patients were
handled.
The new DSM-V criteria for
delirium published recently indicate
that non-comatose patients with a
reduced level of arousal of acute
onset should be classified as having
severe inattention and cognitive
change, and hence delirium. We
agree that such patients can be delir-
ious. Nevertheless, it should be noted
that the same criteria—which corre-
spond to a RASS-2/-3 level—can also
apply for sedated healthy volunteers,
and patients with uneventful postop-
erative course during awakening from
anesthesia.
By no means do we suggest that
delirium should not be considered in
sedated patients. However, we ques-
tion the specificity of the assessments
tools CAM-ICU and ICDSC in seda-
ted patients who cannot hold eye
contact for 10 s. In contrast to what
has been proposed for the CAM-ICU
[4], we suggest to use the delirium
assessment tools after sedation stop,
and to indicate the level of con-
sciousness during the assessment. An
exclusive diagnosis of delirium is
impossible before effects of sedation
are ruled out. Regular sedation stops
have been proven to improve out-
come and reduce resource use.
We should make every effort not to
miss a diagnosis of delirium. At the
same time, misdiagnosing persistent
sedation as delirium is dangerous as
well: a recent delirium trial was pre-
maturely stopped because of
increased mortality in the treatment
group [5]. In this study, almost 40 %
of the included patients had a nega-
tive RASS, half of them a RASS of
-2. In our view, sedation should be
managed with a protocolized
approach including a sedation goal
and frequent assessments, and not
with a delirium screening tool.
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